TrialMovement disorders : official journal of the Movement Disorder Society2026
Observations on an Open-Label Phase 1/2 Dopamine Gene Therapy Trial (OXB-102/Axo-Lenti-PD) in People with Parkinson's Disease.
Simon Rowe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.